CH 2 Neonatal Pulmonary Physiology and Pathophysiology Flashcards

1
Q

A near term infant (34 - 36 weeks gestation) is at risk of presenting with what 4 pathologies?

A
  • Hyaline membrane disease HMD
  • Pulmonary Hypertension
  • Sepsis
  • Pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the most common newborn disorders treated with ECMO ?

A
  • MAS
  • CDH
  • Sepsis
  • Pneumonia
  • Idiopathic Pulmonary Hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Surfactant is composed of several phospholipids which lower surface tension of the alveolar walls.

Why is surfactant important during the initial opening of the alveolar walls?

What secretes surfactant ?

A
  • Prevention of subsequent atelectasis

- Secreted by Type II alveolar cells in the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is HMD characterized ?

A

Hyaline membrane disease is characterized by:

  • (lack of surfactant)
  • Massive alveolar atelectasis > Hypoxia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 2 indicators of pulmonary maturity?

A

By G week 35:

  1. ) Lecithin : Sphingomyelin = 2 : 1
  2. ) Presence of Phosphatidyl glycerol (PG)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the major constituent of surfactant ?

A

Lecithin comprises 50 - 75% of all phospholipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Control of fetal pulmonary circulation are modulated by several agents, what are the 2 most important VASODILATORS?

A
  • Nitric Oxide

- Prostacyclin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Control of fetal pulmonary circulation are modulated by several agents, what are the 2 most important VASOCONSTRICTORS?

What are 2 secondary vasoconstrictors?

A
  • Endothelium-1
  • Platelet activating factor

Secondary Vasoconstrictors:

  • Leukotrienes
  • Thromboxane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A near term infant with HMD should be treated with what therapy before considering ECMO ?

A
  • Surfactant
  • HFV
  • Inhaled Nitric Oxide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In term infants, what can turn off surfactant production ?

A
  • Acidosis

- Hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lung Compliance (CL) formula =

A

Volume / Pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lung compliance is decreased in patients with HMD and therefore, an increase in pressure is needed for expansion of the lungs.
Lung Compliance Normal values range from ?

What values do we often see in HMD pts ?

A

1 - 4 cc/cmH2O/Kg

1/4 - 1/5 of the above + increase work of breathing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What treatment should i use for a patient with HMD ?

Why ?

A

Continuous Positive Pressure Ventilation (CPAP)

  • Opens the alveoli
  • Decreases atelectasis
  • Decreases the work of breathing
  • Increases lung compliance
  • Increases oxygenation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 7 predisposition factors for HMD ?

A
  • Prematurity
  • Perinatal asphyxia
  • Maternal diabetes A,B,C
  • Family HX of HMD
  • 2nd twin
  • C Section w/o labor
  • Male
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Risks for HMD can be decreased by doing the following:

A
  • Glucocorticoid admin to the mother 24 - 48 before birth.
  • Maternal toxemia
  • Premature / Prolonged rupture of the membranes.
  • Lecithin : Sphingomyelin > 2 : 1
  • Presence of Phosphatidyl glycerol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How would a clinician determine if an infant is surfactant deficient and would benefit from artificial surfactant ?

A

Clinicians must use clinical findings.

  • X-Rays
  • Required intubation (ETT)
  • FiO2 > 40 mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Infants with HMD requiring FiO2 > .50 would benifit from recruiting collapsed alveoli. How can we achieve this ?

A
  • Nasal CPAP
  • High Flow Nasal Cannula
  • Longer inspiratory times > .5 sec
  • High Frequency Oscillatory Ventilation (HFOV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where should we keep blood gases for patients with HMD ?

A

pH 7.28
PaCO2 45-50 mmHg
PaO2 50 - 65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What plays a role in the development of bronchopulmonary dysplagia (BPD) ?

A
  • Oxygen &
  • Ventilator therapy

Therefore these patients should be aggressively weaned from these therapies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is bronchopulmonary dysplagia (BPD) characterized?

A

Thickening and eventual necrosis of:

  • Alveolar walls
  • Basement membranes
  • Bronchiolar Epithelial lining layers

Atelectasis & fibrosis are present
Diffusion of Oxygen is impaired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

5 - 30% pf patients with bronchopulmonary dysplagia (BPD die of what ?

A
  • Infection

- Cor Pulmonale

22
Q

Retinopathy of Prematurity (ROP) destroys the normal architecture of the eye which results in blindness. ROP is related to what?

A
  • Hyperoxymia
  • Large swings in oxygenation in the premature.
  • Decrease gestational age
  • Hypotension
  • Acidosis
23
Q

Meconium Aspiration Syndrome (MAS) is secondary to hypoxia or stress and results in respiratory distress.
What are the two forms of lung pathology that can form ?

A
  1. ) Emphysema from ball-valving or partial obstruction

2. ) Atelectatis from total obstruction

24
Q

What is the major component of the pathophysiology of Meconium Aspiration Syndrome (MAS)?

A

1.) PPHTN

Air leaks are common

25
Q

Maternal factors causing risk for MAS ?

A
  1. ) Toxemia
  2. ) HTN
  3. ) Heavy Smoker
  4. ) Chronic Respiratory or Cardiac disease
  5. ) Poor Nutrition
  6. ) > 42 week gestation
26
Q

Mechanical Obstruction combined with Chemical Inflammation as in the case of Meconium Aspiration Syndrome (MAS) results in what ?

A
  • ↑ PVR
  • Opening of Fetal shunts
    = PPHN
27
Q

What neonatal population is the largest treated with ECMO ?

A

Meconium Aspiration Syndrome (MAS)

28
Q

In regards to Meconium Aspiration Syndrome (MAS), what has been shown to turn off surfactant production ?

A
  • Meconium &

- High Ventilation

29
Q

Meconium Aspiration Syndrome (MAS) ultimately leads to PPHN, what is a common treatment for PPHN ?

A
  • Gentle ventilation with lower peak pressures

- iNO

30
Q

What should NOT be used after meeting ECMO criteria?

A
  • Surfactant
31
Q

Causes of PPHN ?

A
  • Hypertrophy of muscular layers in pulmonary arterioles.
  • Failure of the PA to relax
  • Vasospasm & Constriction due to hypoxia & acidosis
  • Polycythemia, Hypocalcemia, hypoglycemia
32
Q

PPHN is characterized by ?

A
  • R > L shunts

- Mixing in the Ao & LA

33
Q

No difference noted in pre/post ductal blood gases would be indicative of what?

A

Shunt only at the PFO

34
Q

A difference of 15 torr noted in pre/post ductal blood gases would be indicative of what?

A

Shunt at the PDA level

35
Q

PPHN is diagnosed by ?

A
  • Doppler ultrasound will reveal the PDA & PFO
  • Pre/Post ductal blood gas differences
  • Infant who responds to hyperventilation-hyperoxia test
  • “Flip-Flop phenomenom” drop in PaO2 with small changes in ventilation
36
Q

Treatment of PPHN ?

A
  • Prevent Hypoxemia (PaO2 > 100 mmHg)
  • Correct acidosis
  • Partial exchange transfusion
  • Correct hypocalcemia
  • Gentle ventilation
  • Sedation, avoid paralysis
  • iNO
  • Conventional ventilator & HFOV, 1 parameter changed at a time.
37
Q

Congenital Diaphragmatic Hernia (CDH) involves what organs ?

A
  • Large intestines
  • Thoracic entry of the stomach
  • Liver
  • Spleen
38
Q

What are the clinical symptoms of Congenital Diaphragmatic Hernia (CDH) ?

A
  • Severe respiratory distress
  • Cyanosis
  • Dyspnea with scaphoid abdomen
  • Bowel sounds heard over effected area
39
Q

Congenital Diaphragmatic Hernia (CDH) diagnosed with what ?

A

X-Ray

40
Q

Treatment of a patient with a Congenital Diaphragmatic Hernia (CDH) ?

A
  • Address the respiratory distress
  • Gastric decompression
  • Infant positioned with head and thorax higher than the ABD to facilitate downward displacement of the hernia contents.
  • Correct acid/base, consider ECMO
  • Ventilator management as with PPHN
41
Q

Treatment of a patient with a Congenital Diaphragmatic Hernia (CDH) and a PaO2

A
  • Stabilize

- ECMO

42
Q

What are the 2 approaches in repairing CDH ?

A
  1. ) Repair on ECMO once pt has demonstrated to be able to wean off ECMO by idling 8 hrs at 10% flows with adequate PaO2s & PaCO2s.
  2. ) Wean the pt off ECMO and repair the pt within 24 - 48hrs after weaning from ECMO.
43
Q

PPHN

A

Persistence of the fetal circulation after birth

44
Q

HMD

A

Surfactant deficiency

45
Q

MAS

A

Ball-valve obstruction in lung passages

46
Q

Bronchopulmonary Dysplasia (BPD)

A

long term complication of oxygen and ventilator therapy

47
Q

CDH

A

Abdominal organs invade the thorax through a hole in the diaphragm

48
Q

True or False
Identification of clot formation in the arterial side of the ECMO circuit, diffuse fibrin deposition throughout the circuit or circuit age greater than 10 days may be justification for a complete circuit change out.

A

True

49
Q

The mechanism of injury for MAS neonates includes

A
  • Mechanical Obstruction

- Chemical Inflammation

50
Q

True or False:

It would not be unusual for a neonate with meconium aspiration to require a chest tube to relieve pneumothorax

A

True

51
Q

True or False:

Intrauterine asphyxia may stop the production of surfactant, leaving the neonate with a very stiff lung

A

False